HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corey S Davis Selected Research

Naloxone (Narcan)

1/2021Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States.
1/2021Considering the Potential Benefits of Over-the-Counter Naloxone.
1/2021Regional and temporal effects of naloxone access laws on opioid overdose mortality.
1/2021Reducing Opioid Overdose Deaths by Expanding Naloxone Distribution and Addressing Structural Barriers to Care.
11/2018Opioid-overdose laws association with opioid use and overdose mortality.
1/2018Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
1/2018Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid.
1/2018State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies.
4/2017Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
10/2016Co-prescribing naloxone does not increase liability risk.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Corey S Davis Research Topics

Disease

23Opiate Overdose
12/2021 - 08/2014
6Opioid-Related Disorders (Opiate Addiction)
05/2022 - 09/2016
3Substance-Related Disorders (Drug Abuse)
05/2022 - 06/2016
3Pain (Aches)
01/2021 - 10/2016
3COVID-19
01/2021 - 07/2020
1Poisoning
12/2019
1Blood-Borne Infections
11/2019
1Wounds and Injuries (Trauma)
01/2019
1Acute Pain
01/2019
1Chronic Pain
09/2016
1Drug Overdose
08/2015
1Respiratory Insufficiency (Respiratory Failure)
08/2014

Drug/Important Bio-Agent (IBA)

18Naloxone (Narcan)FDA LinkGeneric
01/2021 - 08/2014
12Opioid Analgesics (Opioids)IBA
12/2021 - 08/2015
5Buprenorphine (Subutex)FDA LinkGeneric
05/2022 - 01/2020
4Heroin (Diamorphine)IBA
12/2021 - 12/2019
3Methadone (Dolophine)FDA LinkGeneric
05/2022 - 01/2020
3Pharmaceutical PreparationsIBA
01/2021 - 12/2019
2Narcotic Antagonists (Opioid Antagonists)IBA
01/2021 - 08/2015
1Morphine (MS Contin)FDA LinkGeneric
12/2021
1RV 538 (PDMP)IBA
12/2019
1Fentanyl (Sublimaze)FDA LinkGeneric
11/2019
1Illicit Drugs (Recreational Drugs)IBA
11/2019
1Medical MarijuanaIBA
01/2019

Therapy/Procedure

1Transcutaneous Electric Nerve Stimulation (TENS)
10/2016
1Pain Management
06/2016